Noreen Roth Henig
2020
In 2020, Noreen Roth Henig earned a total compensation of $1.5M as Chief Medical Officer at Kezar Life Sciences.
Compensation breakdown
| Non-Equity Incentive Plan | $174,477 |
|---|---|
| Option Awards | $986,160 |
| Salary | $286,667 |
| Other | $11,697 |
| Total | $1,459,001 |
Henig received $986.2K in option awards, accounting for 68% of the total pay in 2020.
Henig also received $174.5K in non-equity incentive plan, $286.7K in salary and $11.7K in other compensation.
Rankings
In 2020, Noreen Roth Henig's compensation ranked 6,947th out of 13,090 executives tracked by ExecPay. In other words, Henig earned more than 46.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,947 out of 13,090 | 47th |
Division Manufacturing | 2,892 out of 5,624 | 49th |
Major group Chemicals And Allied Products | 1,168 out of 2,257 | 48th |
Industry group Drugs | 1,006 out of 1,957 | 49th |
Industry Pharmaceutical Preparations | 750 out of 1,462 | 49th |
Source: SEC filing on April 26, 2022.
Henig's colleagues
We found two more compensation records of executives who worked with Noreen Roth Henig at Kezar Life Sciences in 2020.